4 months Corvus Pharmaceuticals (NASDAQ:CRVS) Reaches New 12-Month High – Time to Buy? MarketBeat

Corvus Pharmaceuticals (NASDAQ:CRVS) Hits New 12-Month High – Time to Buy?

Nasdaq 100 · Pharmaceuticals